1. Home
  2. ATOS vs NEGG Comparison

ATOS vs NEGG Comparison

Compare ATOS & NEGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • NEGG
  • Stock Information
  • Founded
  • ATOS 2009
  • NEGG 2001
  • Country
  • ATOS United States
  • NEGG United States
  • Employees
  • ATOS N/A
  • NEGG N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • NEGG Other Specialty Stores
  • Sector
  • ATOS Health Care
  • NEGG Consumer Discretionary
  • Exchange
  • ATOS Nasdaq
  • NEGG Nasdaq
  • Market Cap
  • ATOS 120.4M
  • NEGG 122.3M
  • IPO Year
  • ATOS 2012
  • NEGG 2010
  • Fundamental
  • Price
  • ATOS $0.86
  • NEGG $84.45
  • Analyst Decision
  • ATOS Strong Buy
  • NEGG
  • Analyst Count
  • ATOS 3
  • NEGG 0
  • Target Price
  • ATOS $6.25
  • NEGG N/A
  • AVG Volume (30 Days)
  • ATOS 1.3M
  • NEGG 1.2M
  • Earning Date
  • ATOS 11-12-2025
  • NEGG 12-01-2025
  • Dividend Yield
  • ATOS N/A
  • NEGG N/A
  • EPS Growth
  • ATOS N/A
  • NEGG N/A
  • EPS
  • ATOS N/A
  • NEGG N/A
  • Revenue
  • ATOS N/A
  • NEGG $1,313,127,000.00
  • Revenue This Year
  • ATOS N/A
  • NEGG N/A
  • Revenue Next Year
  • ATOS N/A
  • NEGG N/A
  • P/E Ratio
  • ATOS N/A
  • NEGG N/A
  • Revenue Growth
  • ATOS N/A
  • NEGG N/A
  • 52 Week Low
  • ATOS $0.55
  • NEGG $3.32
  • 52 Week High
  • ATOS $1.66
  • NEGG $137.84
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 39.96
  • NEGG 72.10
  • Support Level
  • ATOS $0.86
  • NEGG $43.00
  • Resistance Level
  • ATOS $0.91
  • NEGG $87.20
  • Average True Range (ATR)
  • ATOS 0.05
  • NEGG 8.45
  • MACD
  • ATOS -0.02
  • NEGG 3.93
  • Stochastic Oscillator
  • ATOS 4.01
  • NEGG 93.78

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About NEGG Newegg Commerce Inc.

Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.

Share on Social Networks: